Long-Acting Drug Delivery Technologies and Services Market
Published Year: 2023
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
$4950
Primary Highlights Of The Report
Long-Acting Drug Delivery Technologies and Services Market Report Coverage
How can this report add value to an organization?
Global Long-Acting Drug Delivery Technologies and Services Market Overview
Table of Contents
1 Scope and Definition
1.1 Market Definition
1.2 Key Questions Answered in the Report
1.3 Analyst and Forecast Note
2 Markets: Industry Outlook
2.1 Current and Future State of Long-Acting Drug Delivery Technologies and Services in Industries
2.2 Key Benefits of Long-Acting Drug Delivery
2.3 Market Footprint and Growth Potential, $Million, 2022-2033
2.4 Market Dynamics Overview
2.5 Market Drivers
2.6 Market Restraints
2.7 Market Opportunities
3 Global Long-Acting Drug Delivery Technologies and Services Market (by Technique), 2022-2033
3.1 Technique Summary
3.2 Long-Acting Injectables
3.3 Long-Acting Hydrogels
3.4 Long-Acting Implants
3.5 Long-Acting Microneedles
3.6 Nanocrystal Suspensions
4 Global Long-Acting Drug Delivery Technologies and Services Market (by Dosage Forms), 2022-2033
4.1 Dosage Forms Summary
4.2 Long-acting Injectables
4.3 Long-acting Implantable
4.4 Topical / Transdermal
4.5 Vaginal
4.6 Other Dosage Forms
5 Global Long-Acting Drug Delivery Technologies and Services Market (by Type of Molecule Delivered), 2022-2033
5.1 Type of Molecule Delivered Summary
5.2 Small Molecules
5.3 Biologics
5.4 Other Molecules (Peptides)
6 Global Long-Acting Drug Delivery Technologies and Services Market (by Material Used), 2022-2033
6.1 Material-Used Summary
6.2 Polymer based
6.3 Non-polymer based
7 Global Long-Acting Drug Delivery Market (by Distribution Channels), 2022-2033
7.1 Distribution Channels Summary
7.2 Hospitals and Retail Pharmacies
7.3 Research and Academics
7.4 Others
8 Global Long-Acting Drug Delivery Technologies and Services Market, by Region, 2022-2033
8.1 Regional Summary
8.2 Drivers and Restraints
8.3 North America
8.3.1 U.S.
8.3.2 Canada
8.4 Europe
8.4.1 Germany
8.4.2 U.K.
8.4.3 France
8.4.4 Italy
8.4.5 Spain
8.4.6 Rest-of-Europe
8.5 Asia Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 South Korea
8.5.5 Australia
8.5.6 Rest-of-Asia-Pacific
8.6 Rest-of-the-World
9 Markets - Competitive Benchmarking & Company Profiles
9.1 Competitive Landscape
9.2 Adare Pharma Solutions
9.3 Alkermes
9.4 AMW Gmb
9.5 Camurus AB
9.6 Corium, LLC.
9.7 Creative Biolabs
9.8 Delpor, Inc.
9.9 Durect Corporation
9.10 Hanmi Pharm Co Ltd.
9.11 Heron Therapeutics, Inc.
9.12 Integral BioSystems
9.13 NANEXA AB
